Author:
Rojas-Giménez Marta,Mena-Vázquez Natalia,Romero-Barco Carmen María,Manrique-Arija Sara,Ureña-Garnica Inmaculada,Diaz-Cordovés Gisela,Jiménez-Núñez Francisco Gabriel,Fernández-Nebro Antonio
Reference36 articles.
1. Artritis reumatoide: Impacto de la enfermedad, análisis de los costes asociados y estudio del acceso a fármacos biológicos en las comunidades autónomas;García de Vicuña;Rev Esp Econ Salud.,2010
2. [Systematic review: Safety and efficacy of anti-TNF in elderly patients];Busquets;Reumatol Clin.,2011
3. Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: A real issue, a clinical perspective;Vincent;Ann Rheum Dis.,2013
4. Adverse effects of biologics: A network meta-analysis and Cochrane overview;Singh;Cochrane Database Syst Rev.,2011
5. Economics of biological therapies;Kelly;BMJ.,2009